European Leukemia Trial Registry
Trial: CML Homoharringtonine

More Details
Title Homoharringtonine in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Scientific Title Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine in the Treatment of Patients With Chronic Myeloid Leukemia (CML) With T315I BCR-ABL Gene Mutation
Short Title CML Homoharringtonine
Trialgroup NN
Type of Trial open-label
Disease Chronic myeloic leukemia(CML) All subtypes
Age >= 18 years
Status Active
Start of Recruitment 01.07.2006
Contactperson

General Contact Person
Hochhaus, Prof. Dr. med., Andreas
Tel: +49 (0)3641 932 4201
Fax: +49 (0)3641 932 4202
Email: andreas.hochhaus@med.uni-jena.de

Shortprotocol Shortprotocol
created 11.10.2007 Deniz Gökbuget
changed 30.05.2008 Roswitha Kotthoff
© 2006 ELIC European Leukemia Information Center (Dr. N. Gökbuget, Dr. S. Schäfer) | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org